Human Psychopharmacology-Clinical and Experimental

Papers
(The TQCC of Human Psychopharmacology-Clinical and Experimental is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Effects of lasmiditan on simulated driving performance: Results of two randomized, blinded, crossover studies with placebo and active controls32
A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans18
Psilocybin occasioned mystical‐type experiences16
N,N‐dimethyltryptamine and Amazonian ayahuasca plant medicine16
Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment‐resistant depression14
Efficacy of amisulpride for depressive symptoms in individuals with mental disorders: A systematic review and meta‐analysis14
The effect of cannabidiol on simulated car driving performance: A randomised, double‐blind, placebo‐controlled, crossover, dose‐ranging clinical trial protocol14
Anabolic androgenic steroids used as performance and image enhancing drugs in professional and amateur athletes: Toxicological and psychopathological findings12
Alpha7 nicotinic‐N‐methyl‐D‐aspartate hypothesis in the treatment of schizophrenia and beyond11
Comparison of potential psychiatric drug interactions in six drug interaction database programs: A replication study after 2 years of updates11
Gabapentinoids for treatment of alcohol use disorder: A systematic review and meta‐analysis11
Estimated model of psychotropic polypharmacy for bipolar disorder: Analysis using patients' and practitioners' parameters in the MUSUBI study10
Childhood maltreatment and clinical response to mood stabilizers in patients with bipolar disorder10
Sceletium tortuosum (Zembrin®) ameliorates experimentally induced anxiety in healthy volunteers10
Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: Results from two pilot, proof‐of‐concept, randomized, placebo‐controlled trials10
Potential processes of change in MDMA‐Assisted therapy for social anxiety disorder: Enhanced memory reconsolidation, self‐transcendence, and therapeutic relationships10
Effects of solriamfetol on on‐the‐road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea9
Elevated serum levels of TNF‐α, IL‐6, and IL‐18 in chronic methamphetamine users9
Safety and cardiovascular effects of multiple‐dose administration of aripiprazole and olanzapine in a randomised clinical trial9
Effect of crocin versus fluoxetine in treatment of mild to moderate obsessive‐compulsive disorder: A double blind randomized clinical trial9
Efficacy of naltrexone in borderline personality disorder, a retrospective analysis in inpatients9
High‐dose Vitamin B6 supplementation reduces anxiety and strengthens visual surround suppression8
Inverse correlation between plasma 2‐arachidonoylglycerol levels and subjective severity of depression8
Clozapine‐induced agranulocytosis in Japan: Changes in leukocyte/neutrophil counts before and after discontinuation of clozapine8
Coprescription of mood stabilizers in schizophrenia, dosing, and clinical correlates: An international study8
Ayahuasca may help to improve self‐compassion and self‐criticism capacities8
Effectiveness, tolerability, and dropout rates of vortioxetine in comorbid depression: A naturalistic study8
A phase 1 double‐blind, placebo‐controlled study of zuranolone (SAGE‐217) in a phase advance model of insomnia in healthy adults8
Serotonin transporter availability, neurocognitive function and their correlation in abstinent 3,4‐methylenedioxymethamphetamine users7
Differential effects of different antipsychotic drugs on cognitive function in patients with chronic schizophrenia6
Effects of Korean red ginseng on human gray matter volume and cognitive function: A voxel‐based morphometry study6
Correlation between pharmacokinetics and pharmacogenetics of Selective Serotonin Reuptake Inhibitors and Selective Serotonin and Noradrenaline Reuptake Inhibitors and maternal and neonatal outcomes: R6
Restless Legs Syndrome among patients receiving antipsychotic and antidepressant drugs6
How prevalent and severe is addiction on GABAmimetic drugs in an elderly German general hospital population? Focus on gabapentinoids, benzodiazepines, and z‐hypnotic drugs6
The safety of agomelatine in standard medical practice in depressed patients: A 26‐week international multicentre cohort study6
Role of serotonin transporter and receptor gene polymorphisms in treatment response to selective serotonin reuptake inhibitors in major depressive disorder6
Melatonin and melatonin‐agonists for metabolic syndrome components in patients treated with antipsychotics: A systematic review and meta‐analysis5
Evaluation of memantine's efficacy and safety in the treatment of children with autism spectrum disorder: A systematic review and meta‐analysis5
Duloxetine attenuates pain in association with downregulation of platelet serotonin transporter in patients with burning mouth syndrome and atypical odontalgia5
Safety of switching to brexpiprazole in Japanese patients with schizophrenia: A post‐hoc analysis of a long‐term open‐label study5
Effects ofPanax quinquefolius(American ginseng) on the steady state visually evoked potential during cognitive performance5
Effects of aripiprazole long‐acting injectable antipsychotic on hospitalization in recent‐onset schizophrenia5
Treatment of depression: Are psychotropic drugs appropriately dosed in women and in the elderly? Dosages of psychotropic drugs by sex and age in routine clinical practice5
Pharmacological treatment algorithms for the acute phase, agitation, and maintenance phase of first‐episode schizophrenia: Japanese Society of Clinical Neuropsychopharmacology treatment algorithms4
Inflammatory markers at baseline correlate with subsequent clinical response to quetiapine in patients with bipolar disorder4
The potential role of lysergic acid diethylamide for psychological assisted therapy: A meta‐analysis of randomised controlled trials in healthy volunteers4
An explorative approach to understanding individual differences in driving performance and neurocognition in long‐term benzodiazepine users4
Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment‐free Russian patients with moderate or severe depression: An explorative psychopharmacological st4
Initiation of psychotropic medication in hospitalized patients with COVID‐19: Association with clinical and biological characteristics4
0.02138090133667